Article(id=1329835281076826187, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1329835237376373459, articleNumber=null, orderNo=null, doi=10.13683/j.wph.2024.01.013, pmid=null, cstr=null, oa=null, hot=null, price=null, onlineType=0, articleFormat=0, articleType=null, articleTypeStr=null, receivedDate=1698422400000, receivedDateStr=2023-10-28, revisedDate=null, revisedDateStr=null, acceptedDate=null, acceptedDateStr=null, onlineDate=1794987038153, onlineDateStr=2026-11-18, pubDate=1704816000000, pubDateStr=2024-01-10, doiRegisterDate=null, doiRegisterDateStr=null, onlineIssueDate=1794987038153, onlineIssueDateStr=2026-11-18, onlineJustAcceptDate=null, onlineJustAcceptDateStr=null, onlineFirstDate=null, onlineFirstDateStr=null, sourceXml=null, magXml=null, createTime=1794987038153, creator=13701087609, updateTime=1794987038153, updator=13701087609, issue=Issue{id=1329835237376373459, tenantId=1146029695717560320, journalId=1319690329412173987, year='2024', volume='45', issue='1', pageStart='1', pageEnd='102', issueExtLink='null', onlineDate='null', pubDate='1704816000000', pubDateStr='2024-01-10', beforeIssueId=null, nextIssueId=null, price=null, status=1, issueComplete=1, articleOrder=1, issueType=-1, specialIssue=null, createTime=1794987027734, creator='13701087609', updateTime=1794988176831, updator='13701087609', preIssue=null, nextIssue=null, articleTotal=null, ext={EN=IssueExt(id=1329840057474724591, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1329835237376373459, language=EN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=), CN=IssueExt(id=1329840057478918896, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1329835237376373459, language=CN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=)}, issueFiles=null, downloadFileDto=null}, startPage=77, endPage=83, ext={EN=ArticleExt(id=1329835281290735692, articleId=1329835281076826187, tenantId=1146029695717560320, journalId=1319690329412173987, language=EN, title=Research progress on novel intraocular pressure lowering drugs using trabecular meshwork pathway, columnId=1325221194584162830, journalTitle=World Clinical Drug, columnName=Review, runingTitle=null, highlight=null, articleAbstract=
Glaucoma is a group of neurodegenerative diseases with pathological increase of intraocular pressure (IOP) as the main risk factor. Local use of IOP-lowering drugs is still the first line of treatment. Most of the aqueous humor flows out through the trabecular meshwork (TM) pathway, which is the main site of primary open-angle glaucoma. Therefore, novel IOP lowering drugs targeting the TM pathway are very important for the treatment of glaucoma. This article reviewed the mechanism and progress of Rho kinase inhibitors, nitric oxide donors and other novel IOP lowering drugs in recent years, aiming to provide clinical reference.
, authors=Pei GAN
1, 2, Xueke LIU
2, Xia LI
2, *, authorsList=Pei GAN, Xueke LIU, Xia LI, authorCompany=null, correspAuthors=Xia LI, authorNote=null, correspAuthorsNote=null, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=null, magXml=null, pdfUrl=null, pdf=null, pdfFileSize=null, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=null, mapNumber=null, fund=null), CN=ArticleExt(id=1329835281575948365, articleId=1329835281076826187, tenantId=1146029695717560320, journalId=1319690329412173987, language=CN, title=小梁网途径的新型降眼压药物研究进展, columnId=1325221194743546384, journalTitle=世界临床药物, columnName=综述评论, runingTitle=null, highlight=null, articleAbstract=
青光眼(glaucoma)是一组以病理性眼压(intraocular pressure,IOP)升高为主要危险因素的神经退行性疾病,局部使用降IOP药物仍是其一线疗法。绝大部分房水经小梁网(trabecular meshwork,TM)途径外流,且TM途径是原发性开角型青光眼病变(primary open-angle glaucoma)的主要部位,故针对TM途径的新型降IOP药物对青光眼的治疗至关重要。现就近年来的Rho激酶抑制剂、一氧化氮供体及其他新型降IOP药物的作用机制及进展进行综述,旨在为临床提供参考。
, authors=甘霈
1, 2, 刘雪珂
2, 李霞
2, *, authorsList=甘霈, 刘雪珂, 李霞, authorCompany=null, correspAuthors=李霞, authorNote=
, correspAuthorsNote=
李霞,主任医师,硕士研究生导师,研究方向:青光眼、眼外伤、角膜病。
, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=LZ2TzAmfe1Tc7Usw72NiCA==, magXml=bQqLbZwl0EIA31Ixr6qydg==, pdfUrl=null, pdf=5/ot5b0V4VCkrPuMExA1pw==, pdfFileSize=1589031, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=upuLq/gBv6RHuN/GBLS+XQ==, mapNumber=null, fund=null)}, authors=[Author(id=1329835281907298389, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835281076826187, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329835281986990168, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835281076826187, authorId=1329835281907298389, language=EN, stringName=Pei GAN, firstName=Pei, middleName=null, lastName=GAN, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=
1, 2, address=
1.Ophthalmology Specialty, Shihezi University School of Medicine, Shihezi 832099, Xinjiang Uygur Autonomous Region, China
2.Department of Ophthalmology, Xinjiang 474 Hospital, Urumqi 830013, Xinjiang Uygur Autonomous Region, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329835282049904729, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835281076826187, authorId=1329835281907298389, language=CN, stringName=甘霈, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=
1, 2, address=
1.石河子大学医学院眼科学专业,新疆 石河子 832099
2.新疆四七四医院眼科,新疆 乌鲁木齐 830013, bio={"content":"
甘霈,硕士研究生,研究方向:青光眼、眼外伤。
"}, bioImg=null, bioContent=
甘霈,硕士研究生,研究方向:青光眼、眼外伤。
, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329835281739526222, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835281076826187, xref=1., ext=[AuthorCompanyExt(id=1329835281743720527, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835281076826187, companyId=1329835281739526222, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=
1.Ophthalmology Specialty, Shihezi University School of Medicine, Shihezi 832099, Xinjiang Uygur Autonomous Region, China), AuthorCompanyExt(id=1329835281752109136, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835281076826187, companyId=1329835281739526222, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=
1.石河子大学医学院眼科学专业,新疆 石河子 832099)]), AuthorCompany(id=1329835281823412305, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835281076826187, xref=2., ext=[AuthorCompanyExt(id=1329835281831800914, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835281076826187, companyId=1329835281823412305, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=
2.Department of Ophthalmology, Xinjiang 474 Hospital, Urumqi 830013, Xinjiang Uygur Autonomous Region, China), AuthorCompanyExt(id=1329835281840189523, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835281076826187, companyId=1329835281823412305, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=
2.新疆四七四医院眼科,新疆 乌鲁木齐 830013)])]), Author(id=1329835282117013595, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835281076826187, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329835282205093981, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835281076826187, authorId=1329835282117013595, language=EN, stringName=Xueke LIU, firstName=Xueke, middleName=null, lastName=LIU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=
2, address=
2.Department of Ophthalmology, Xinjiang 474 Hospital, Urumqi 830013, Xinjiang Uygur Autonomous Region, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329835282255425630, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835281076826187, authorId=1329835282117013595, language=CN, stringName=刘雪珂, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=
2, address=
2.新疆四七四医院眼科,新疆 乌鲁木齐 830013, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329835281823412305, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835281076826187, xref=2., ext=[AuthorCompanyExt(id=1329835281831800914, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835281076826187, companyId=1329835281823412305, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=
2.Department of Ophthalmology, Xinjiang 474 Hospital, Urumqi 830013, Xinjiang Uygur Autonomous Region, China), AuthorCompanyExt(id=1329835281840189523, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835281076826187, companyId=1329835281823412305, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=
2.新疆四七四医院眼科,新疆 乌鲁木齐 830013)])]), Author(id=1329835282330923104, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835281076826187, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1329835282410614882, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835281076826187, authorId=1329835282330923104, language=EN, stringName=Xia LI, firstName=Xia, middleName=null, lastName=LI, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=
2, *, address=
2.Department of Ophthalmology, Xinjiang 474 Hospital, Urumqi 830013, Xinjiang Uygur Autonomous Region, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329835282469335139, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835281076826187, authorId=1329835282330923104, language=CN, stringName=李霞, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=
2, *, address=
2.新疆四七四医院眼科,新疆 乌鲁木齐 830013, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329835281823412305, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835281076826187, xref=2., ext=[AuthorCompanyExt(id=1329835281831800914, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835281076826187, companyId=1329835281823412305, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=
2.Department of Ophthalmology, Xinjiang 474 Hospital, Urumqi 830013, Xinjiang Uygur Autonomous Region, China), AuthorCompanyExt(id=1329835281840189523, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835281076826187, companyId=1329835281823412305, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=
2.新疆四七四医院眼科,新疆 乌鲁木齐 830013)])])], keywords=[Keyword(id=1329835282582581348, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835281076826187, language=EN, orderNo=1, keyword=glaucoma), Keyword(id=1329835282649690213, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835281076826187, language=EN, orderNo=2, keyword=trabecular meshwork), Keyword(id=1329835282708410470, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835281076826187, language=EN, orderNo=3, keyword=intraocular pressure lowering drug), Keyword(id=1329835282779713639, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835281076826187, language=EN, orderNo=4, keyword=drug therapy), Keyword(id=1329835282884571240, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835281076826187, language=CN, orderNo=1, keyword=青光眼), Keyword(id=1329835282976845929, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835281076826187, language=CN, orderNo=2, keyword=小梁网), Keyword(id=1329835284604235882, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835281076826187, language=CN, orderNo=3, keyword=降眼压药物), Keyword(id=1329835284738453611, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835281076826187, language=CN, orderNo=4, keyword=药物治疗)], refs=[Reference(id=1329835284956557421, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835281076826187, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[1], rfOrder=0, authorNames=null, journalName=null, refType=null, unstructuredReference=Kang JM, Tanna AP. Glaucoma[J]. Med Clin North Am, 2021, 105(3): 493-510., articleTitle=null, refAbstract=null), Reference(id=1329835285044637806, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835281076826187, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[2], rfOrder=1, authorNames=null, journalName=null, refType=null, unstructuredReference=Kapetanakis VV, Chan MP, Foster PJ,
et al. Global variations and time trends in the prevalence of primary open angle glaucoma (POAG): a systematic review and meta-analysis[J]. Br J Ophthalmol, 2016, 100(1): 86-93., articleTitle=null, refAbstract=null), Reference(id=1329835285120135279, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835281076826187, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[3], rfOrder=2, authorNames=null, journalName=null, refType=null, unstructuredReference=刘家崎, 李凤鸣. 实用眼科学[M]. 第3版. 北京: 人民卫生出版社, 2020: 378-380., articleTitle=null, refAbstract=null), Reference(id=1329835285216604272, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835281076826187, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[4], rfOrder=3, authorNames=null, journalName=null, refType=null, unstructuredReference=Ostler E, Rhee D, Burney E,
et al. Advances in medical therapy for glaucoma[J]. Curr Opin Ophthalmol, 2021, 32(2): 129-133., articleTitle=null, refAbstract=null), Reference(id=1329835285300490353, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835281076826187, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[5], rfOrder=4, authorNames=null, journalName=null, refType=null, unstructuredReference=Rao PV, Pattabiraman PP, Kopczynski C. Role of the Rho GTPase/Rho kinase signaling pathway in pathogenesis and treatment of glaucoma: bench to bedside research[J]. Exp Eye Res, 2017, 158: 23-32., articleTitle=null, refAbstract=null), Reference(id=1329835285375987826, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835281076826187, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[6], rfOrder=5, authorNames=null, journalName=null, refType=null, unstructuredReference=Riento K, Ridley AJ. Rocks: multifunctional kinases in cell behaviour[J]. Nat Rev Mol Cell Biol, 2003, 4(6): 446-456., articleTitle=null, refAbstract=null), Reference(id=1329835285468262515, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835281076826187, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[7], rfOrder=6, authorNames=null, journalName=null, refType=null, unstructuredReference=郝一宪, 魏慧霞, 郭大东, 等. Rho/ROCK信号通路在眼科疾病发生发展中的作用研究进展[J]. 国际眼科杂志, 2021, 21(4): 640-643., articleTitle=null, refAbstract=null), Reference(id=1329835285556342900, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835281076826187, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[8], rfOrder=7, authorNames=null, journalName=null, refType=null, unstructuredReference=叶俏娜, 余敏斌, 杨扬帆. 小梁网异常与原发性开角型青光眼的关系[J]. 国际眼科纵览, 2022, 46(2): 150-156., articleTitle=null, refAbstract=null), Reference(id=1329835285652811893, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835281076826187, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[9], rfOrder=8, authorNames=null, journalName=null, refType=null, unstructuredReference=Gonzalez LE, Boylan PM. Netarsudil for the treatment of open-angle glaucoma and ocular hypertension: a literature review[J]. Ann Pharmacother, 2021, 55(8): 1025-1036., articleTitle=null, refAbstract=null), Reference(id=1329835285778641014, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835281076826187, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[10], rfOrder=9, authorNames=null, journalName=null, refType=null, unstructuredReference=Luo N, Jiang X, Hao M,
et al. Efficacy and safety of netarsudil/latanoprost fixed-dose combination
vs monotherapy in open-angle glaucoma or ocular hypertension: a systematic review and meta-analysis of randomized controlled trials[J]. Front Med (Lausanne), 2022, 9: 923308., articleTitle=null, refAbstract=null), Reference(id=1329835285875110007, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835281076826187, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[11], rfOrder=10, authorNames=null, journalName=null, refType=null, unstructuredReference=Shiuey EJ, Mehran NA, Ustaoglu M,
et al. The effectiveness and safety profile of netarsudil 0.02% in glaucoma treatment: real-world 6-month outcomes[J]. Graefes Arch Clin Exp Ophthalmol, 2022, 260(3): 967-974., articleTitle=null, refAbstract=null), Reference(id=1329835285954801784, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835281076826187, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[12], rfOrder=11, authorNames=null, journalName=null, refType=null, unstructuredReference=Meirick TM, Mudumbai RC, Zhang MM,
et al. Punctal stenosis associated with topical netarsudil use[J]. Ophthalmology, 2022, 129(7): 765-770., articleTitle=null, refAbstract=null), Reference(id=1329835286030299257, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835281076826187, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[13], rfOrder=12, authorNames=null, journalName=null, refType=null, unstructuredReference=Chang EL, Emmel DK, Teng CC,
et al. Anterior subcapsular cataract formation with long-term topical netarsudil treatment for glaucoma[J]. J Glaucoma, 2022, 31(1): 60-63., articleTitle=null, refAbstract=null), Reference(id=1329835286109991034, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835281076826187, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[14], rfOrder=13, authorNames=null, journalName=null, refType=null, unstructuredReference=Sit AJ, Gupta D, Kazemi A,
et al. Netarsudil improves trabecular outflow facility in patients with primary open angle glaucoma or ocular hypertension: a phase 2 study[J]. Am J Ophthalmol, 2021, 226: 262-269., articleTitle=null, refAbstract=null), Reference(id=1329835286206460027, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835281076826187, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[15], rfOrder=14, authorNames=null, journalName=null, refType=null, unstructuredReference=Kaufman AR, Elhusseiny AM, Edward DP,
et al. Topical netarsudil for treatment of glaucoma with elevated episcleral venous pressure: a pilot investigation in sturge-weber syndrome[J]. Eur J Ophthalmol, 2023, 33(5): 1969-1976., articleTitle=null, refAbstract=null), Reference(id=1329835286281957500, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835281076826187, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[16], rfOrder=15, authorNames=null, journalName=null, refType=null, unstructuredReference=Xu H, Thomas MT, Lee D,
et al. Response to netarsudil in goniotomy-treated eyes and goniotomy-naïve eyes: a pilot study[J]. Graefes Arch Clin Exp Ophthalmol, 2022, 260(9): 3001-3007., articleTitle=null, refAbstract=null), Reference(id=1329835286407786621, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835281076826187, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[17], rfOrder=16, authorNames=null, journalName=null, refType=null, unstructuredReference=Elhusseiny AM, Abbasian J. Topical netarsudil 0.02% as adjunctive therapy in refractory pediatric glaucoma[J]. J AAPOS, 2022, 26(6): 300., articleTitle=null, refAbstract=null), Reference(id=1329835286474895486, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835281076826187, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[18], rfOrder=17, authorNames=null, journalName=null, refType=null, unstructuredReference=Asrani S, Bacharach J, Holland E,
et al. Fixed-dose combination of netarsudil and latanoprost in ocular hypertension and open-angle glaucoma: pooled efficacy/safety analysis of phase 3 MERCURY-1 and -2[J]. Adv Ther, 2020, 37(4): 1620-1631., articleTitle=null, refAbstract=null), Reference(id=1329835286567170175, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835281076826187, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[19], rfOrder=18, authorNames=null, journalName=null, refType=null, unstructuredReference=Garnock-Jones KP. Ripasudil: first global approval[J]. Drugs, 2014, 74(18): 2211-2215., articleTitle=null, refAbstract=null), Reference(id=1329835286676222080, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835281076826187, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[20], rfOrder=19, authorNames=null, journalName=null, refType=null, unstructuredReference=Sato S, Hirooka K, Nitta E,
et al. Additive intraocular pressure lowering effects of the Rho kinase inhibitor, ripasudil in glaucoma patients not able to obtain adequate control after other maximal tolerated medical therapy[J]. Adv Ther, 2016, 33(9): 1628-1634., articleTitle=null, refAbstract=null), Reference(id=1329835286743330945, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835281076826187, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[21], rfOrder=20, authorNames=null, journalName=null, refType=null, unstructuredReference=Tanihara H, Kakuda T, Sano T,
et al. Long-term intraocular pressure-lowering effects and adverse events of ripasudil in patients with glaucoma or ocular hypertension over 24 months[J]. Adv Ther, 2022, 39(4): 1659-1677., articleTitle=null, refAbstract=null), Reference(id=1329835286818828418, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835281076826187, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[22], rfOrder=21, authorNames=null, journalName=null, refType=null, unstructuredReference=Kusuhara S, Nakamura M. Ripasudil hydrochloride hydrate in the treatment of glaucoma: safety, efficacy, and patient selection[J]. Clin Ophthalmol, 2020, 14: 1229-1236., articleTitle=null, refAbstract=null), Reference(id=1329835286923686019, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835281076826187, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[23], rfOrder=22, authorNames=null, journalName=null, refType=null, unstructuredReference=Tanihara H, Yamamoto T, Aihara M,
et al. Ripasudil-brimonidine fixed-dose combination
vs ripasudil or brimonidine: two phase 3 randomized clinical trials[J]. Am J Ophthalmol, 2023, 248: 35-44., articleTitle=null, refAbstract=null), Reference(id=1329835286999183492, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835281076826187, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[24], rfOrder=23, authorNames=null, journalName=null, refType=null, unstructuredReference=Syed ZA, Rapuano CJ. Rho kinase (ROCK) inhibitors in the management of corneal endothelial disease[J]. Curr Opin Ophthalmol, 2021, 32(3): 268-274., articleTitle=null, refAbstract=null), Reference(id=1329835287087263877, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835281076826187, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[25], rfOrder=24, authorNames=null, journalName=null, refType=null, unstructuredReference=Hida Y, Nakamura S, Nishinaka A,
et al. Effects of ripasudil, a ROCK inhibitor, on retinal edema and nonperfusion area in a retinal vein occlusion murine model[J]. J Pharmacol Sci, 2018, 137(2): 129-136., articleTitle=null, refAbstract=null), Reference(id=1329835287183732870, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835281076826187, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[26], rfOrder=25, authorNames=null, journalName=null, refType=null, unstructuredReference=Ko JA, Komatsu K, Minamoto A,
et al. Effects of ripasudil, a Rho-kinase inhibitor, on scar formation in a mouse model of filtration surgery[J]. Curr Eye Res, 2023, 48(9): 826-835., articleTitle=null, refAbstract=null), Reference(id=1329835287288590471, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835281076826187, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[27], rfOrder=26, authorNames=null, journalName=null, refType=null, unstructuredReference=Minami Y, Song YS, Ishibazawa A,
et al. Effect of ripasudil on diabetic macular edema[J]. Sci Rep, 2019, 9(1): 3703., articleTitle=null, refAbstract=null), Reference(id=1329835287359893640, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835281076826187, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[28], rfOrder=27, authorNames=null, journalName=null, refType=null, unstructuredReference=Han B, Song M, Li L,
et al. The application of nitric oxide for ocular hypertension treatment[J]. Molecules, 2021, 26(23): 7306., articleTitle=null, refAbstract=null), Reference(id=1329835287427002505, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835281076826187, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[29], rfOrder=28, authorNames=null, journalName=null, refType=null, unstructuredReference=Reina-Torres E, De Ieso ML, Pasquale LR,
et al. The vital role for nitric oxide in intraocular pressure homeostasis[J]. Prog Retin Eye Res, 2021, 83: 100922., articleTitle=null, refAbstract=null), Reference(id=1329835289012449418, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835281076826187, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[30], rfOrder=29, authorNames=null, journalName=null, refType=null, unstructuredReference=Grześk G, Witczyńska A, Węglarz M,
et al. Soluble guanylyl cyclase activators-promising therapeutic option in the pharmacotherapy of heart failure and pulmonary hypertension[J]. Molecules, 2023, 28(2): 861., articleTitle=null, refAbstract=null), Reference(id=1329835289083752587, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835281076826187, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[31], rfOrder=30, authorNames=null, journalName=null, refType=null, unstructuredReference=Shahidullah M, Mandal A, Wei G,
et al. Nitric oxide regulation of Na, K-ATPase activity in ocular ciliary epithelium involves Src family kinase[J]. J Cell Physiol, 2014, 229(3): 343-352., articleTitle=null, refAbstract=null), Reference(id=1329835289142472844, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835281076826187, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[32], rfOrder=31, authorNames=null, journalName=null, refType=null, unstructuredReference=Kawase K, Vittitow JL, Weinreb RN,
et al. Long-term safety and efficacy of latanoprostene bunod 0.024% in Japanese subjects with open-angle glaucoma or ocular hypertension: the JUPITER study[J]. Adv Ther, 2016, 33(9): 1612-1627., articleTitle=null, refAbstract=null), Reference(id=1329835289205387405, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835281076826187, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[33], rfOrder=32, authorNames=null, journalName=null, refType=null, unstructuredReference=Harasymowycz P, Royer C, Cui AX,
et al. Short-term efficacy of latanoprostene bunod for the treatment of open-angle glaucoma and ocular hypertension: a systematic literature review and a network meta-analysis[J]. Br J Ophthalmol, 2022, 106(5): 640-647., articleTitle=null, refAbstract=null), Reference(id=1329835289268301966, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835281076826187, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[34], rfOrder=33, authorNames=null, journalName=null, refType=null, unstructuredReference=Zhou B, Bekerman VP, Khouri AS. Use of latanoprostene bunod as adjunctive glaucoma therapy in refractory glaucoma[J]. J Curr Glaucoma Pract, 2022, 16(3): 166-169., articleTitle=null, refAbstract=null), Reference(id=1329835289331216527, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835281076826187, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[35], rfOrder=34, authorNames=null, journalName=null, refType=null, unstructuredReference=El-Nimri NW, Moghimi S, Penteado RC,
et al. Comparison of the effects of latanoprostene bunod and timolol on retinal blood vessel density: a randomized clinical trial[J]. Am J Ophthalmol, 2022, 241: 120-129., articleTitle=null, refAbstract=null), Reference(id=1329835289402519696, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835281076826187, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[36], rfOrder=35, authorNames=null, journalName=null, refType=null, unstructuredReference=Yang Z, Wu J, Wu K,
et al. Identification of nitric oxide-donating ripasudil derivatives with intraocular pressure lowering and retinal ganglion cell protection activities[J]. J Med Chem, 2022, 65(17): 11745-11758., articleTitle=null, refAbstract=null), Reference(id=1329835289461239953, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835281076826187, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[37], rfOrder=36, authorNames=null, journalName=null, refType=null, unstructuredReference=Walters TR, Kothe AC, Boyer JL,
et al. A randomized, controlled comparison of NCX470(0.021%, 0.042%, and 0.065%) and latanoprost 0.005% in patients with open-angle glaucoma or ocular hypertension: the dolomites study[J]. J Glaucoma, 2022, 31(6): 382-391., articleTitle=null, refAbstract=null), Reference(id=1329835289519960210, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835281076826187, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[38], rfOrder=37, authorNames=null, journalName=null, refType=null, unstructuredReference=Fan W, Song M, Li L,
et al. Endogenous dual stimuli-activated NO generation in the conventional outflow pathway for precision glaucoma therapy[J]. Biomaterials, 2021, 277: 121074., articleTitle=null, refAbstract=null), Reference(id=1329835289587069075, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835281076826187, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[39], rfOrder=38, authorNames=null, journalName=null, refType=null, unstructuredReference=Amankwa CE, Gondi SR, Dibas A,
et al. Novel thiol containing hybrid antioxidant-nitric oxide donor small molecules for treatment of glaucoma[J]. Antioxidants (Basel), 2021, 10(4): 575., articleTitle=null, refAbstract=null), Reference(id=1329835289649983636, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835281076826187, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[40], rfOrder=39, authorNames=null, journalName=null, refType=null, unstructuredReference=Kim J, Park DY, Bae H,
et al. Impaired angiopoietin/Tie2 signaling compromises Schlemm's canal integrity and induces glaucoma[J]. J Clin Invest, 2017, 127(10): 3877-3896., articleTitle=null, refAbstract=null), Reference(id=1329835289729675413, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835281076826187, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[41], rfOrder=40, authorNames=null, journalName=null, refType=null, unstructuredReference=Li G, Nottebaum AF, Brigell M,
et al. A small molecule inhibitor of VE-PTP activates Tie2 in Schlemm's canal increasing outflow facility and reducing intraocular pressure[J]. Invest Ophthalmol Vis Sci, 2020, 61(14): 12., articleTitle=null, refAbstract=null), Reference(id=1329835289817755798, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835281076826187, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[42], rfOrder=41, authorNames=null, journalName=null, refType=null, unstructuredReference=Brigell M, Withers B, Buch A,
et al. Tie2 activation via VE-PTP inhibition with razuprotafib as an adjunct to latanoprost in patients with open angle glaucoma or ocular hypertension[J]. Transl Vis Sci Technol, 2022, 11(1): 7., articleTitle=null, refAbstract=null), Reference(id=1329835289897447575, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835281076826187, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[43], rfOrder=42, authorNames=null, journalName=null, refType=null, unstructuredReference=Ho LTY, Osterwald A, Ruf I,
et al. Role of the autotaxin-lysophosphatidic acid axis in glaucoma, aqueous humor drainage and fibrogenic activity[J]. Biochim Biophys Acta Mol Basis Dis, 2020, 1866(1): 165560., articleTitle=null, refAbstract=null), Reference(id=1329835289972945048, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835281076826187, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[44], rfOrder=43, authorNames=null, journalName=null, refType=null, unstructuredReference=Nakamura N, Yamagishi R, Honjo M,
et al. Effects of topical TGF-β
1, TGF-β
2, ATX, and LPA on IOP elevation and regulation of the conventional aqueous humor outflow pathway[J]. Mol Vis, 2021, 27: 61-77., articleTitle=null, refAbstract=null), Reference(id=1329835290048442521, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835281076826187, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[45], rfOrder=44, authorNames=null, journalName=null, refType=null, unstructuredReference=Hunziker D, Reinehr S, Palmhof M,
et al. Synthesis, characterization, and
in vivo evaluation of a novel potent autotaxin-inhibitor[J]. Front Pharmacol, 2022, 12: 699535., articleTitle=null, refAbstract=null), Reference(id=1329835290136522906, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835281076826187, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[46], rfOrder=45, authorNames=null, journalName=null, refType=null, unstructuredReference=Yemanyi F, Raghunathan V. Lysophosphatidic acid and IL-6 trans-signaling interact via YAP/TAZ and STAT3 signaling pathways in human trabecular meshwork cells[J]. Invest Ophthalmol Vis Sci, 2020, 61(13): 29., articleTitle=null, refAbstract=null), Reference(id=1329835290249769115, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835281076826187, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[47], rfOrder=46, authorNames=null, journalName=null, refType=null, unstructuredReference=张灿, 王贺, 陈冬燕, 等. TGF-β
1受体ALK1和ALK5在翼状胬肉和正常结膜组织中的差异表达[J]. 国际眼科杂志, 2021, 21(11): 1962-1967., articleTitle=null, refAbstract=null), Reference(id=1329835290367209628, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835281076826187, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[48], rfOrder=47, authorNames=null, journalName=null, refType=null, unstructuredReference=Aoshima K, Inagaki S, Takagi Y,
et al. ALK5 inhibitor acts on trabecular meshwork cell and reduces intraocular pressure[J]. Exp Eye Res, 2023, 227: 109382., articleTitle=null, refAbstract=null), Reference(id=1329835290442707101, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835281076826187, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[49], rfOrder=48, authorNames=null, journalName=null, refType=null, unstructuredReference=Teplitsky JE, Vinokurtseva A, Armstrong JJ,
et al. ALK5 inhibition of subconjunctival scarring from glaucoma surgery: effects of SB-431542 compared to mitomycin c in human tenon's capsule fibroblasts[J]. Transl Vis Sci Technol, 2023, 12(2): 31., articleTitle=null, refAbstract=null), Reference(id=1329835290518204574, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835281076826187, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[50], rfOrder=49, authorNames=null, journalName=null, refType=null, unstructuredReference=吕水利, 高晓博, 王鹏, 等. 他汀类药物的多效性研究进展[J]. 人民军医, 2020, 63(3): 289-292., articleTitle=null, refAbstract=null), Reference(id=1329835290589507743, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835281076826187, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[51], rfOrder=50, authorNames=null, journalName=null, refType=null, unstructuredReference=Talwar N, Musch DC, Stein JD. Association of daily dosage and type of statin agent with risk of open-angle glaucoma[J]. JAMA Ophthalmol, 2017, 135(3): 263-267., articleTitle=null, refAbstract=null), Reference(id=1329835290660810912, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835281076826187, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[52], rfOrder=51, authorNames=null, journalName=null, refType=null, unstructuredReference=Song XY, Chen YY, Liu WT,
et al. Atorvastatin reduces IOP in ocular hypertension
in vivo and suppresses ECM in trabecular meshwork perhaps via FGD4[J]. Int J Mol Med, 2022, 49(6): 76., articleTitle=null, refAbstract=null), Reference(id=1329835290736308385, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835281076826187, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[53], rfOrder=52, authorNames=null, journalName=null, refType=null, unstructuredReference=Wei H, Wang J, Wang R,
et al. Effects of atorvastatin on the function of Tenon's capsule fibroblasts in human eyes[J]. Int Ophthalmol, 2023, 43(10): 3707-3715., articleTitle=null, refAbstract=null), Reference(id=1329835290824388770, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835281076826187, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[54], rfOrder=53, authorNames=null, journalName=null, refType=null, unstructuredReference=Kim ML, Sung KR, Kwon J,
et al. Neuroprotective effect of statins in a rat model of chronic ocular hypertension[J]. Int J Mol Sci, 2021, 22(22): 12500., articleTitle=null, refAbstract=null), Reference(id=1329835290904080547, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835281076826187, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[55], rfOrder=54, authorNames=null, journalName=null, refType=null, unstructuredReference=袁滢惠, 段吉隆, 惠子, 等. 靶向ATR激酶抑制剂治疗癌症的研究进展[J]. 药学学报, 2022, 57(3): 593-604., articleTitle=null, refAbstract=null), Reference(id=1329835290966995108, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835281076826187, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[56], rfOrder=55, authorNames=null, journalName=null, refType=null, unstructuredReference=Wu WH, Bonnet S, Shimauchi T,
et al. Potential for inhibition of checkpoint kinases 1/2 in pulmonary fibrosis and secondary pulmonary hypertension[J]. Thorax, 2022, 77(3): 247-258., articleTitle=null, refAbstract=null), Reference(id=1329835291042492581, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835281076826187, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[57], rfOrder=56, authorNames=null, journalName=null, refType=null, unstructuredReference=Huang L, Ye Q, Lan C,
et al. AZD6738 inhibits fibrotic response of conjunctival fibroblasts by regulating checkpoint kinase 1/p53 and PI3K/AKT pathways[J]. Front Pharmacol, 2022, 13: 990401., articleTitle=null, refAbstract=null), Reference(id=1329835291117990054, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835281076826187, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[58], rfOrder=57, authorNames=null, journalName=null, refType=null, unstructuredReference=Huang L, Wei Z, Wang X,
et al. AZD6738 decreases intraocular pressure and inhibits fibrotic response in trabecular meshwork through CHK1/p53 pathway[J]. Biochem Pharmacol, 2022, 206: 115340., articleTitle=null, refAbstract=null)], funds=[Fund(id=1329835284851699820, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835281076826187, awardId=2022jzbjl18, language=CN, fundingSource=新疆军区总医院北京路医疗区重点扶持科研项目(2022jzbjl18), fundOrder=null, country=null)], companyList=[AuthorCompany(id=1329835281739526222, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835281076826187, xref=1., ext=[AuthorCompanyExt(id=1329835281743720527, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835281076826187, companyId=1329835281739526222, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=
1.Ophthalmology Specialty, Shihezi University School of Medicine, Shihezi 832099, Xinjiang Uygur Autonomous Region, China), AuthorCompanyExt(id=1329835281752109136, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835281076826187, companyId=1329835281739526222, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=
1.石河子大学医学院眼科学专业,新疆 石河子 832099)]), AuthorCompany(id=1329835281823412305, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835281076826187, xref=2., ext=[AuthorCompanyExt(id=1329835281831800914, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835281076826187, companyId=1329835281823412305, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=
2.Department of Ophthalmology, Xinjiang 474 Hospital, Urumqi 830013, Xinjiang Uygur Autonomous Region, China), AuthorCompanyExt(id=1329835281840189523, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835281076826187, companyId=1329835281823412305, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=
2.新疆四七四医院眼科,新疆 乌鲁木齐 830013)])], figs=null, attaches=null, journal=Journal(id=1319689997550452896, delFlag=0, nameCn=世界临床药物, nameEn=World Clinical Drug, nameHistory1=null, nameHistory2=null, issn=1672-9188, eissn=null, cn=31-1939/R, coden=SLYHAA, periodic=0, language=CN, oaType=null, ccby=null, superviseOffice=null, ownerOffice=null, pubOffice=null, editorOffice=null, officeType=null, aims=null, clcCode=null, officeProv=null, officeCity=null, officeAddr=null, officeZip=null, officeEmail=null, officePhone=null, editDirector=null, officeDirector=null, officeDirectorPhone=null, officeStaffNum=null, officeEmpNum=null, coverPicUrl=9c6IkcJKa1cF20h1u6lJeQ==, journalPrice=null, startedYear=null, abbrevIsoEn=World Clinical Drug, journalRemark=null, publicationField=null, createdTime=1792568214072, updatedTime=1792747519563, createdBy=18614031015, updatedBy=13701087609, firstLetterCn=S, firstLetterEn=S, subjectCode=Medical and Pharmaceutical Sciences, subjectName=null, subjectCodeEn=Medical and Pharmaceutical Sciences, subjectNameEn=null, picCn=9c6IkcJKa1cF20h1u6lJeQ==, picEn=MRqUlTwfL6oqIHNy7eyFZQ==, jcr=null, cjcr=null, exts=[JournalExt(id=1320442059660570919, language=CN, name=世界临床药物, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747519650, updatedTime=1792747519650, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=http://www.jwph.com.cn/journalx_sjlcyw/authorLogOn.action, submissionEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorLogOn.action, submissionReviewUrl=http://www.jwph.com.cn/journalx_sjlcyw/expertLogOn.action, submissionCeEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorInChiefLogOn.action, submissionAeEditorUrl=, option={"copyright":""}), JournalExt(id=1320442059723485480, language=EN, name=World Clinical Drug, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747519665, updatedTime=1792747519665, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=http://www.jwph.com.cn/journalx_sjlcyw/authorLogOn.action, submissionEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorLogOn.action, submissionReviewUrl=http://www.jwph.com.cn/journalx_sjlcyw/expertLogOn.action, submissionCeEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorInChiefLogOn.action, submissionAeEditorUrl=, option={"copyright":""})], databaseList=null, tenantJournalId=1319690329412173987, websiteList=[Website(id=1321427104911179915, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690329412173987, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/sjlcyw/CN, language=CN, createTime=1792982372739, createBy=18614031015, updateTime=1792982514949, updateBy=18614031015, name=世界临床药物-中文, tplId=1146099689490845704, title=世界临床药物, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428428256031726, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=articleTextType, value=kx, createTime=1792982688249, updateTime=1792982688249, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428193117163, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=banner, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic?fileId=RR/csUBcM48ejcuaaK5s0g==, createTime=1792982688234, updateTime=1792982688234, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428302169073, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=grayFlag, value=0, createTime=1792982688260, updateTime=1792982688260, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428172145642, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=logo, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic?fileId=yyY2emcxcV1CfIeK9tH8ZA==, createTime=1792982688229, updateTime=1792982688229, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428327334899, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=minRunFlag, value=0, createTime=1792982688266, updateTime=1792982688266, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428226671597, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic, createTime=1792982688242, updateTime=1792982688242, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428314751986, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=silenceFlag, value=0, createTime=1792982688263, updateTime=1792982688263, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428209894380, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_cn_619/, createTime=1792982688238, updateTime=1792982688238, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428268614639, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=themeColor, value=null, createTime=1792982688252, updateTime=1792982688252, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428289586160, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=themeStyle, value=.style-1 .main-menu ul>li {
margin-right: 18px;
}
@media (max-width: 1442px) {
.style-1 .main-menu ul>li a {
font-size: 16px;
padding: 10px 0;
}
}, createTime=1792982688257, updateTime=1792982688257, creator=18614031015, updator=18614031015)]), Website(id=1321427104990871693, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690329412173987, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/sjlcyw/EN, language=EN, createTime=1792982372758, createBy=18614031015, updateTime=1792982556355, updateBy=18614031015, name=世界临床药物-英文, tplId=1146101810881728533, title=World Clinical Drug, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428446820021244, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=articleTextType, value=kx, createTime=1792982692675, updateTime=1792982692675, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446757106681, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=banner, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic?fileId=RR/csUBcM48ejcuaaK5s0g==, createTime=1792982692660, updateTime=1792982692660, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447109428223, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=grayFlag, value=0, createTime=1792982692744, updateTime=1792982692744, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446736135160, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=logo, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic?fileId=yyY2emcxcV1CfIeK9tH8ZA==, createTime=1792982692655, updateTime=1792982692655, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447142981632, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=minRunFlag, value=0, createTime=1792982692752, updateTime=1792982692752, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446790661115, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic, createTime=1792982692668, updateTime=1792982692668, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447130399745, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=silenceFlag, value=0, createTime=1792982692749, updateTime=1792982692749, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446769689594, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_en_623/, createTime=1792982692663, updateTime=1792982692663, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446832604157, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=themeColor, value=null, createTime=1792982692678, updateTime=1792982692678, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447092651006, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=themeStyle, value=.style-1 .main-menu ul>li {
margin-right: 18px;
}
@media (max-width: 1442px) {
.style-1 .main-menu ul>li a {
font-size: 16px;
padding: 10px 0;
}
}, createTime=1792982692740, updateTime=1792982692740, creator=18614031015, updator=18614031015)])], journalTitle=世界临床药物, weixinUrl=null, journalUrl=http://www.jwph.com.cn/, iacademicId=null, status=1, seqNo=null, journalTitleEn=World Clinical Drug, journalPhotoCn=9c6IkcJKa1cF20h1u6lJeQ==, journalPhotoEn=MRqUlTwfL6oqIHNy7eyFZQ==, journalFirstLetter=S, journalRecommend=null, journalNew=null, journalCollection=null, jcrJf=null, cjcrJf=null, jcrJfStr=null, cjcrJfStr=null, submissionFirstDecision=null, sciSubjectClassification=null, casSubjectClassification=null, citeScore=null, totalCitationFrequency=null, icpCode=null, psCode=null, advertisingLicenseCode=null, copyrightInformation=null, country=null, option=, provinceCode=null, provinceName=null, collectFlag=false, interPubPlatform=, interPubPlatformUrl=null), detailUrlCn=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/10.13683/j.wph.2024.01.013, detailUrlEn=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/10.13683/j.wph.2024.01.013, pdfUrlCn=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/PDF/10.13683/j.wph.2024.01.013, pdfUrlEn=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/PDF/10.13683/j.wph.2024.01.013, aliStartDate=0, aliEndDate=0, collectionFlag=false, citedCount=null, citedUrl=null, previewStatus=0, delFlag=0, hasFullText=0, orderTime=1704816000000, fullTextJson=null, articleText=null, reference=null)